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Abstract
This paper reviews the literature exploring issues around methamphetamine and injury. There was
a paucity of peer reviewed quantitative research and a lack of large scale epidemiological studies.
Further sources described cases and others described injury risk as part of an overall review of
methamphetamine misuse. Thus, a number of limitations and potential biases exist within the
literature. The main areas where associations were noted or extrapolated with methamphetamine
use and injury were around driving and violence. Other associations with injury related to
methamphetamine manufacture. There was also circumstantial evidence for third party injury (that
is injury to those not specifically involved in drug use or drug manufacture); however, the available
data are inadequate to confirm these associations/risks.
Introduction
Methamphetamine is a stimulant drug with high depend-
ence liability, and is a commonly misused illicit substance
worldwide. The drug first appeared as a legal drug in nasal
decongestant preparations during the 1930s, but meth-
amphetamine has been used for non-medical purposes
wherever it has been readily available. Methamphetamine
is a powerful psychostimulant which has a high depend-
ence liability [1,2] and can be readily manufactured from
precursor substances which are common ingredients of
'over the counter' cold remedies [3,4]. Methamphetamine
can be smoked, snorted, injected or swallowed and its
effects can last up to 12 hours.
The desired effects from the use of illicit methampheta-
mine include euphoria, decreased need for food and
sleep, increased mental alertness and energy levels, disin-
hibition, sense of wellbeing and increased confidence [5].
Effects are dose-dependent and onset ranges from 20–40
minutes if swallowed, 3–5 minutes when snorted, and
almost immediately if smoked or taken intravenously.
Smoking and injecting users report an intensely pleasura-
ble wave of sensation or 'rush' [6].
Repeated and chronic use of methamphetamine may
result in undesirable and dangerous effects including psy-
chotic symptoms such as severe paranoia, hallucinations
and delusions of persecution, anxiety symptoms, agita-
tion and affective symptoms such as depression and
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mood swings [3,7,8]. Other reported effects of chronic use
include insomnia, malnutrition, involuntary movements,
increased psychomotor activity, elevated blood pressure
and heart rate sometimes resulting in myocardial infarc-
tion or stroke [9-12]. Continued use has a high depend-
ence probability [4].
The most common symptoms of withdrawal from use are
depression, [2,13] fatigue, restlessness, nervousness, feel-
ings of alienation and irritation, craving for more meth-
amphetamine, severe paranoia, hallucinations and
delusions [14-16]. The physical effects of withdrawal can
include tremor, sweating, headaches, dizziness, dry
mouth and gastrointestinal problems. Severity of with-
drawal depends on length and magnitude of use [5] and
may be compounded by any pre-existing mental health
problems [17].
The purpose of this paper is to provide a critical review of
the English language peer reviewed and 'grey' literature on
the association between methamphetamine use and
injury.
Literature reviewed for this paper
The Medline, Embase, PsychInfo, ERIC and Factiva data-
bases were searched over the period 1997 to 2005 for ref-
erences to injuries and other harms related to
methamphetamine or "P' use. Key terms included: meth-
amphetamine, street drugs (ice, crank, pure or crystal meth), or
illicit drugs combined with injur$, harm$ or risk$. Search
terms varied slightly depending on terminology used in
individual databases. In addition the websites of drug
agencies such as the United National Office for Drugs and
Crime (UNODC), the National Institute on Drug Abuse
(NIDA), and the Australian Crime Commission were
searched for relevant reports. Key studies were checked for
further references. Additional material was sourced from
those working in the drug misuse and control fields in
New Zealand. The result was the creation of an Endnote
database containing 174 references to research, informa-
tion bulletins and reports and other relevant publications
on the topic of methamphetamine or 'P' use and its poten-
tial for harm to the user and others, including children
and emergency service workers.
Much of the available evidence on which this review has
been based is of limited scope and variable quality in
terms of gold standard research. In practice we found no
population-based studies or large trials which provided
insight into the burden of methamphetamine use and its
association with injury. Whilst providing limited insight
into some of the potential issues of injury associated with
the use of methamphetamine, only limited conclusions
can be drawn from the data.
Injury associated with methamphetamine use
In news reports and public discussion both in New Zea-
land and internationally, methamphetamine use has been
regularly implicated in deaths and injuries arising from
violent crime, homicide, suicide, and police car chases
[18-25]. Much of this association is speculative, inferred
from the known effects of the drug on the body and on
behaviour and from the conditions of manufacture of the
drug [18,26]. Despite the circumstantial and anecdotal
implications, the involvement of methamphetamine in
injury (in particular with regard to violence) is not well
understood, [27] and the literature offers only snippets of
data on the type and rate of trauma injury and criminal
harms associated with methamphetamine use.
Logan, Fligner and Haddix's review of Washington State
deaths in which methamphetamine was detected in the
blood of the deceased found the direct toxic effects of the
drug caused or contributed to over a third of the deaths.
Most of the methamphetamine deaths occurred at high
blood concentrations of more than 0.5 mg/L. Death was
also found to occur with concentrations as low as 0.05
mg/L – although usually in conjunction with other drugs
or significant natural disease. A large proportion of the
deaths were classified as homicide (27%) or suicide
(15%) [28].
An examination of methamphetamine related deaths in
Taiwan assigned 59% to accidental causes (including
unintended overdose), with 14% homicidal, 11% suicidal
and 13% natural causes (in the presence of a pathological
illness). The majority of the fatalities were aged between
20–40 years and were predominantly male [29].
Evidence from the United States (US) indicates that in
California, while methamphetamine use by trauma
patients increased significantly over the period 1989–
1994, cocaine rates remained constant and there was a
decrease in alcohol rates [30]. Methamphetamine was
most commonly associated with vehicular trauma, while
cocaine positivity correlated with interpersonal violence.
Furthermore, the mechanisms of injury associated with
methamphetamine use in trauma patients resembled
those associated with alcohol. The authors note that no
causal relationship was found between methampheta-
mine use and trauma, and that results may be biased, as
there was testing bias towards males, minorities, those
involved in violence and those in car crashes.
A retrospective study which compared 461 patients with
positive toxicology screens for methamphetamine and
32,156 others presenting at an emergency department in
the US, found a significant association between metham-
phetamine use and injury from trauma among the meth-
amphetamine-positive patients, the majority with bluntHarm Reduction Journal 2006, 3:14 http://www.harmreductionjournal.com/content/3/1/14
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trauma injuries involving motor vehicle accidents. Other
injuries involved interpersonal trauma resulting from
gunshot wounds, stabbings and assaults. Again, the
results may be biased due to selection bias in screening for
drugs [31].
A study of trauma patients in Hawaii noted that patients
testing positive for amphetamines were more likely to
have self-harmed, were older and had stayed significantly
longer in hospital than those who tested negative. They
concluded that stimulant users utilised resources in the
trauma centre which were "out of proportion to injury
severity" [32].
Much of the study data on methamphetamine-related
injury are derived from blood testing of emergency
department users and the deceased. Significant testing
bias may exist [30], and there may also be an underesti-
mation of drug use as those who admit to using drugs are
usually tested [31].
Injury associated with motor vehicle use
The same propensities for risk-taking as well as those for
paranoia, fearlessness and aggression might also be
expected to have an adverse effect on driving behaviours
[18,33]. There is some evidence that, at low doses in
fatigued subjects, methamphetamine improves motor
skills relevant to driving [18,34]. However, overall the evi-
dence base concerning the impact of amphetamine-type
stimulants on driving is equivocal, largely because there is
little research evidence from which firm conclusions can
be drawn [18]. A 1996 study of 28 cases of drivers arrested
or killed in traffic accidents who tested positive for meth-
amphetamine, concluded that methamphetamine "at any
concentration is likely to produce symptoms that are
inconsistent with safe driving" [35].
An Australian investigation into the incidence of alcohol
and drugs in fatally injured drivers found that while alco-
hol was the drug involved most often in road crashes, its
presence had decreased over the decade while cannabi-
noids and opiates had increased. Stimulants, mainly
methamphetamine, had a much larger presence in the
blood of truck drivers, than in car drivers or motorcyclists,
who had been fatally injured [36]. In a further study by
Longo and colleagues examining the relationship
between substance use and culpability for 2,500 injured
drivers, found that there was a higher proportion of stim-
ulant-positive culpable drivers than drug free drivers,
although the results were not statistically significant [37].
Drummer and colleagues' 10 year multi-centre study of
drugs in drivers killed in Australia found that 4.1% (138)
of the 3398 cases had stimulants in their blood, and that
whilst only 3.4% of car drivers tested positive, 23% of
truck drivers tested positive [38].
Another Australian study found that poly-drug use was
common among traffic offence detainees – nearly a quar-
ter tested positive to amphetamines (almost exclusively
methamphetamine). Twenty percent tested positive to
amphetamine plus another drug, and that other drug was
most frequently cannabis [39]. As concomitant use of
other drugs is likely to further affect judgement and ability
to drive, the potential for drivers to be influenced by other
drugs such as alcohol and cannabis in addition to
amphetamine is considered to be a key issue by Australian
Police [18].
The detection of drug-impaired drivers is far more difficult
and complex than the detection of alcohol-impaired driv-
ers [18], as blood concentration of methamphetamine is
not a good measure of its effect on driving performance –
particularly as drug withdrawal is as much a problem as
drug intoxication [35,40]. Indeed, Logan describes a US
case study of accidents involving methamphetamine-pos-
itive drivers where the drivers' behaviours leading to the
accident were more consistent with methamphetamine
withdrawal than intoxication [35].
One of the primary effects of methamphetamine is the
forestalling of fatigue and Australian police are aware of
the use of amphetamines in general by some long distance
truck drivers [18]. The extent to which use of such sub-
stances contributes to crashes is unclear [18]. While
higher methamphetamine blood concentrations may
have harmful effects on self-perception, critical judge-
ment, attention, risk taking, mood and motor restlessness,
small amounts of amphetamines may improve driving
performance in tired drivers [35].
The period following methamphetamine intoxication,
when the direct effect is waning, is a period associated
with fatigue, anxiety, irritability and 'microsleeps' [35].
These conditions are not conducive to safe driving [35],
and may be a mechanism of crash causation [36]. The
post-intoxication phase may also, in chronic cases,
include delusions, hallucinations and suicidal ideation
possibly impacting on driving.
With regard to injury or loss of life, high-speed car chases
are among the riskiest of policing activities [18]. Whilst in
New Zealand, as in Australia, there is currently no research
evidence to indicate that offender use of methampheta-
mine is a significant factor in such pursuits, circumstantial
evidence does suggest that methamphetamine use may
increase both the likelihood and dangers of users becom-
ing involved in high-speed police car chases [18].
Aitken and colleagues [41], in an Australian study using
focus groups and a survey of 160 injecting drug users, also
reported that methamphetamine users were very likely toHarm Reduction Journal 2006, 3:14 http://www.harmreductionjournal.com/content/3/1/14
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link their drug use with driving – often driving for the
'thrill' of it. Evidence suggested some of the motivations
for methamphetamine use, such as thrill seeking and the
need for excitement, as well as the effects of amphetamine
intoxication, may be both more conducive to engagement
in a chase, and to other risky driving behaviours and
'more exciting' types of criminal activities. These behav-
iours may contribute to offenders being more likely to be
pursued by police [18].
As with driving, there are also concerns with the use of
other machinery either in the workplace or at home. For
example, reports have suggested that methamphetamine
is used within workplace settings to increase performance
and endurance at work [42-44].
Injury associated with violence
The combination of drugs and alcohol has long been
regarded as a major risk factor for violence and crime, and
the extent of drug use has been found to be a predictor of
criminal activity [45]. Violence is not a psychopharmaco-
logical attribute of methamphetamine use, but as states of
intoxication and withdrawal are often accompanied by
disinhibition, agitation, paranoia, and delusions [5],
these may lead to hostile feelings and violent behaviour
[1,27]. In light of this, there are many aspects of the effects
(aggression, paranoia, irrational behaviour and disinhibi-
tion) and patterns of methamphetamine use and the con-
text of its manufacture that give rise to concerns about this
particular drug's potential relationship with violent crime
[46].
US law enforcement agencies have associated use of the
potent forms of methamphetamine with levels of criminal
violence far exceeding those experienced in relation to any
other drug use and have suggested a potential relationship
between methamphetamine use and 'thrill'-related crimes
[47]. Klee and Morris [45], suggest that while the criminal
activity of heroin users is often driven by the need for
money to fund their drug use, the criminal activity of
amphetamine users was motivated more by the need for
excitement and thrills.
In Queensland, health workers have recently been experi-
encing increased instances of clients with paranoid and
aggressive behaviours associated with methamphetamine
use [48]. A particular population of concern are intrave-
nous drug users who had previously been using heroin
and had begun using methamphetamine during a period
of 'heroin drought', and who exhibited clear deleterious
changes in their mood and behaviour. The Queensland
Ambulance Service also reported increased attendance at
amphetamine-related cases over this period noting that
they were very resource intensive because of the potential
for the patient to be agitated and aggressive [48]. Metham-
phetamine-related aggressive behaviour is also an emerg-
ing issue of concern for law enforcement officers [49].
In a recent New Zealand study of drug enforcement offic-
ers' perceptions, two-thirds reported noticing changes in
the level of violence being committed by methampheta-
mine users, although it is not possible to relate this to
offences. Forty percent of those who reported change,
reported noticing "more serious violence", and 26%
reported noticing "more domestic violence" [50]. Family and
relationship breakdown is typically associated with drug
dependence, and any aggression and violence resulting as
a consequence of methamphetamine-induced paranoia,
hostility and agitation is particularly likely to be manifest
in domestic violence [3].
Methamphetamine users are not simply potential perpe-
trators, but also appear to be victims of violence. A study
of 1016 methamphetamine-dependent individuals
enrolled in a treatment programme in the US showed that
suffering physical violence was reported by 85% of
women and 70% of men [51], although the actual contri-
bution of the drug to the violence experienced is difficult
to assess.
Injury related to manufacture
Manufacture of potent forms of methamphetamine
involves relatively simple chemical processes [4,52,53].
Whilst simple, the manufacture of methamphetamine
involves the use of highly flammable, very toxic and cor-
rosive chemicals [54,55]. Injuries can occur through a
range of methamphetamine manufacturing mechanisms.
Exposure to toxic chemicals can occur via skin absorption
and inhalation; burns, eye injuries, and poisoning may
occur, and the injuries will depend on the method of
manufacture [56], which will depend on the availability
of precursor substances. Literature on the conditions of
illicit manufacture and clandestine laboratory-related
injuries is largely descriptive, or inferential.
Groups of people placed at risk are the methamphetamine
manufacturers, other adults and children who may be res-
ident where a laboratory is located, neighbours, later
occupants of the site, police and forensic scientists [57].
Emergency workers may also incur some health risks if
not adequately protected and there are wider environ-
mental risks involved in the storage and disposal of highly
toxic chemicals [54,57,58].
Many manufacturers may also be heavy methampheta-
mine users and have been reported to regularly take risks
when handling dangerous chemicals and in the processes
of manufacture [59,60]. In the US, one in five laboratories
is discovered because of an explosion, and there is a risk
of severe burns to anyone near a laboratory [55]. CaseHarm Reduction Journal 2006, 3:14 http://www.harmreductionjournal.com/content/3/1/14
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reports of patients involved in methamphetamine manu-
facture detail second-degree burns, and anhydrous
ammonia ocular injury [61]. A retrospective study of case
notes of 507 burns units admissions in 1999–2001 found
34 were either involved in the use of methamphetamine,
or its production [62]. The authors also noted the cost of
treatment was high, with average length of stay being
around 16 days at a mean cost of $78,580 US. In a retro-
spective case series analysis of patients with facial burns
admitted to a US burns unit, methamphetamine was
believed to be responsible for almost 10% of those admit-
ted [63]. A recent report to the Centers for Disease Control
and Prevention (US) of notifications from 16 states to the
Hazardous Substances Emergency Events Surveillance
noted that 1,791 (4%) were associated with methamphet-
amine manufacture. Almost 1,000 people were injured –
the most common injuries were respiratory irritation
(39%), headache (26%), eye irritation (8%), and burns
(8%) and included one fatality [64]. Methamphetamine
manufacturing has also resulted in death by phosphine
gas poisoning [65].
Special consideration must be given to environmental
decontamination of methamphetamine laboratory sites
and to the protection of exposed populations during this
process [54]. There are high hazard risks associated with
the closing down and deconstruction of a laboratory, and
subsequent scene investigation. Law enforcement agents
need specialist knowledge and equipment and ongoing
training to safely dismantle idiosyncratic and unsafe labo-
ratories [42]. The mobility and makeshift nature of clan-
destine laboratories exacerbates the dangers and increases
the risks of harm to others. Methamphetamine laborato-
ries have reportedly been found in sites as diverse as a
motel room, a farm granary, a farm water tank and the
back of a car [66-69].
There is potential for secondary contamination of emer-
gency department (ED) personnel in cases where individ-
uals contaminated by the processes of methamphetamine
manufacture have presented at medical centres [57,70].
The risk of injury through secondary contamination
depends on the toxicity and concentration of the sub-
stance on the patients' hair, skin and clothing, and the
duration of contact that ED personnel have with the
patient [70].
Disposal of chemical waste products from methampheta-
mine production creates human and environmental risk
[71]. Illicit disposal is likely to be indiscriminate, such as
directly into the ground, down drains and toilets – espe-
cially with the arrival of police – and concealed chemical
stocks may be dangerously stored in unsafe containers
[59]. The chemicals used and the gases produced can
leach into and contaminate the fabric and furnishings of
buildings, and an abandoned laboratory in a domestic
residence poses risks to any unwitting future occupants
[72-74].
Injuries and children
Methamphetamine is easily and frequently manufactured
in private residences, and there are reports of increasing
numbers of children presenting to emergency centres in
the US suffering the effects of exposure to methampheta-
mine in their homes [75]. The National Drug Intelligence
Centre report on children at risk notes that 2028 children
were present at seized methamphetamine laboratory sites
in the US and that 35% of those tested positive for toxic
levels of chemicals [76]. The report lists the direct injuries
that children present at methamphetamine laboratories
are exposed to, including inhalation, burns and more
indirect injuries from neglect, malnutrition, and abuse
[76].
Mecham and Melini [75] discuss toxicological and social
consequences of children being present at methampheta-
mine laboratories, including caregiver neglect, access to
weapons and targets of sexual abuse. Children exposed to
methamphetamine also demonstrate respiratory distress,
agitation and hyperactivity [75]. Other reported health
effects included gastrointestinal problems, chemical
burns, brain damage, headaches, and skin and eye irrita-
tion [77]. Kolecki's review of 18 paediatric patients [12],
inadvertently poisoned with methamphetamine shows
that they commonly presented with tachycardia, agita-
tion, inconsolable crying and irritability, and vomiting.
The more dependent a child is on its caregiver, the more
consistently the passive exposure affects the child. Infants
and toddlers in the home for long periods are likely to be
the most vulnerable group.
Synthesis of review
Robust data on injuries associated with methampheta-
mine use are scant and with substantial gaps in the avail-
able scientific knowledge. In part, whilst studies and case
series suggest that methamphetamine use has been associ-
ated with behaviours that carry injury risk, causality is dif-
ficult to establish. In the absence of formal
epidemiological analyses, confounding by other factors
that may also be associated with methamphetamine use
and injury has been inadequately addressed. Other limita-
tions of the literature include measurement bias, lack of
clear definition of injury and a lack of standardised
approaches to measurement.
In evaluating the current literature on injury associated
with methamphetamine use, it is also essential to note
international differences, e.g. in route of administration,
user subgroups and functional use, and use patterns with
other substances. Furthermore, study populations andHarm Reduction Journal 2006, 3:14 http://www.harmreductionjournal.com/content/3/1/14
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data sources commonly accessed and relevant tended to
come from particular populations. The clinical research
sourced predominantly originated in the US and much is
based on work undertaken by treatment organisations
with an established cocaine treatment background. Thus
attention is often directed at cocaine-derived issues. Also
samples taken from those in treatment cannot be expected
to be representative of the general population and many
subjects have had a history of other drug and/or intrave-
nous drug use.
Similarly the studies undertaken in Australia have largely
been undertaken by organisations funded to research HIV
and therefore tend to focus on the use of methampheta-
mine among men who have sex with men (MSM) (the
largest HIV risk group in Australia) and in particular MSM
in relation to high risk sexual practices. This tends to
present what may be a misleading picture of methamphet-
amine as a 'gay' drug in Australia.
A number of links that have been made, such as those
between unsafe driving and methamphetamine use, crim-
inal violence and methamphetamine use, are largely infer-
ential and based on what is known about the
psychophysiological effects of methamphetamine. Much
of the police data are reducible to a single source or set of
sources that have been recycled through Australian and
New Zealand documents.
Research outputs from hospital emergency departments
often use drug testing of blood samples to validate clinical
reporting. However, universal blood testing of patients at
sites providing emergency care is limited by ethical and
practical considerations, and emergency department pro-
vider decisions about who to test have been shown to be
subject to bias – with males, ethnic minority groups and
those involved in motorcycle crashes being more likely to
be tested. As long as the biases remain constant this may
be a reliable indicator of changes of rates, but not of over-
all levels of use.
Data collection from emergency departments could pro-
vide a valuable insight into violence, injuries, issues
around child welfare and domestic violence. However, it
is difficult to ensure that the idiosyncratic aspects of rou-
tinely collected data within emergency departments do
not undermine opportunities to collect data. A more fea-
sible form of data collection is likely to be researcher ini-
tiated and to be prospective in nature. Such data could
inform the development of interventions designed to
reduce risk associated with both methamphetamine use
and methamphetamine manufacture, in particular in rela-
tion to children and domestic violence. Testing of patients
would need to be conducted both for use of methamphet-
amine and for contaminants associated with manufac-
ture.
Further research into the burden of injury associated with
methamphetamine use and driving requires attention and
includes road traffic incidents associated with police car
chases. More qualitative investigation of the function of
methamphetamine use among drivers, as well as the
impact the drug has on ability to perform complex physi-
cal and cognitive actions will provide information for the
development of interventions.
One of the most common causes of injury associated with
methamphetamine use is likely to be violence. Police
arrest and conviction data might be utilised to target inter-
ventions at individuals as well as to aid in exploration of
the setting associated with such events. However, routine
collection of data from emergency departments, police,
environmental health and other related organisations is
costly, time consuming and often impractical. Ultimately,
engagement and consultation with the various agencies
and the co-operation of those agencies and their staff is
essential to any mobilisation of the will to institute proce-
dures that would further the collection of useful data.
Of particular concern is the potential impact of metham-
phetamine-related injury risk on child welfare. It may be
prudent to begin to explore injury prevention and harm
reduction interventions relating to this, in parallel with
any research and data collection. Raising awareness of the
potential adverse effects of methamphetamine use and
manufacture on children is an urgent issue.
There is also a case to be made for closer attention to be
paid to the specificities of methamphetamine itself with
regards to particular locations and situations in which it is
used, as to a certain extent, a more general approach may
overlook important aspects of the drug, such as its effects
and its particular methods and patterns of use. This would
require not only further targeted epidemiological study,
but also more ethnographic research that might further
contribute to an understanding of the social practises of
methamphetamine use, the meanings attached to it and
the social contexts in which use occurs.
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